Comparing two eye scanners for spotting new blood vessels in macular degeneration
Compares two eye imaging devices in people with age-related macular degeneration and large detachments.
Plain-language title generated from the registry record
Registry title: Comparison of the Sensibility of Swept Source Optical Coherence Tomography Devices in the Detection of Neovascularisation in Large Pigment Epithelium Detachments
Key facts
- Where
- Créteil, FranceSee the site
Where in France
- Centre Hospitalier Intercommunal de CréteilCréteil, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Trieste
- Trial code
- NCT07143526
- Record updated
- 27 August 2025
- Original description
The goal of this observational study is to compare swept source optical coherence tomography devices ability to detect macular neovascularisation when there is a large pigment epithelium detachment higher than 250 micronsRead full original descriptionShow less
Comparison of Two Swept-source Optical Coherence Tomography Angiography (OCTA) Devices (Bmizar and Plexelite) for Detecting Macular Neovascularisation With Large (More Than 250 Microns) Pigment Epithelium Detachment (PED) in Age Related Macular Degeneration
The goal of this observational study is to compare swept source optical coherence tomography devices ability to detect macular neovascularisation when there is a large pigment epithelium detachment higher than 250 microns
Inclusion: Patients treated for neovascular age related macular degeneration (AMD); Presence of a pigmentary epithelium detachment higher than 250 microns measured on structural optical coherence tomography (OCT).
Exclusion: Poor image quality or signal strength; Undefined retina layers.